Overview

Dorna Therapeutics is a preclinical stage immuno-oncology company that develops capabilities to stimulate both innate and adaptive immune responses directly and selectively within solid tumors to create a universal therapeutic cancer vaccine. The systemic administration of a single drug compound with tumor accumulating capabilities will allow patients to immunize themselves against their own cancers for a long lasting curative effect.